ANVS
Price
$2.61
Change
-$0.03 (-1.14%)
Updated
Jun 3 closing price
Capitalization
50.86M
70 days until earnings call
VTYX
Price
$2.01
Change
+$0.02 (+1.01%)
Updated
Jun 4, 10:48 AM (EDT)
Capitalization
141.61M
64 days until earnings call
Interact to see
Advertisement

ANVS vs VTYX

Header iconANVS vs VTYX Comparison
Open Charts ANVS vs VTYXBanner chart's image
Annovis Bio
Price$2.61
Change-$0.03 (-1.14%)
Volume$390.74K
Capitalization50.86M
Ventyx Biosciences
Price$2.01
Change+$0.02 (+1.01%)
Volume$2.8K
Capitalization141.61M
ANVS vs VTYX Comparison Chart
Loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANVS vs. VTYX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a Buy and VTYX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (ANVS: $2.61 vs. VTYX: $1.99)
Brand notoriety: ANVS and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 94% vs. VTYX: 112%
Market capitalization -- ANVS: $50.86M vs. VTYX: $141.61M
ANVS [@Biotechnology] is valued at $50.86M. VTYX’s [@Biotechnology] market capitalization is $141.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 1 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • ANVS’s FA Score: 1 green, 4 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, ANVS is a better buy in the long-term than VTYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 5 TA indicator(s) are bullish while VTYX’s TA Score has 6 bullish TA indicator(s).

  • ANVS’s TA Score: 5 bullish, 4 bearish.
  • VTYX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VTYX is a better buy in the short-term than ANVS.

Price Growth

ANVS (@Biotechnology) experienced а +27.94% price change this week, while VTYX (@Biotechnology) price change was +13.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

ANVS is expected to report earnings on Aug 13, 2025.

VTYX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTYX($142M) has a higher market cap than ANVS($50.9M). VTYX YTD gains are higher at: -9.132 vs. ANVS (-48.111). ANVS has higher annual earnings (EBITDA): -30.4M vs. VTYX (-135.48M). VTYX has more cash in the bank: 229M vs. ANVS (12.6M). ANVS (0) and VTYX (0) have equivalent revenues.
ANVSVTYXANVS / VTYX
Capitalization50.9M142M36%
EBITDA-30.4M-135.48M22%
Gain YTD-48.111-9.132527%
P/E RatioN/AN/A-
Revenue00-
Total Cash12.6M229M6%
Total DebtN/A10.5M-
TECHNICAL ANALYSIS
Technical Analysis
ANVSVTYX
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 22 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DYN13.270.57
+4.49%
Dyne Therapeutics
JFIN15.200.42
+2.84%
Jiayin Group
QLYS142.561.85
+1.31%
Qualys
GD276.040.33
+0.12%
General Dynamics Corp
KINS15.73-0.31
-1.93%
Kingstone Companies

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
-1.14%
ADXN - ANVS
43%
Loosely correlated
-0.12%
MDGL - ANVS
36%
Loosely correlated
+4.31%
EWTX - ANVS
33%
Poorly correlated
+1.02%
VTYX - ANVS
32%
Poorly correlated
-2.45%
AXON - ANVS
31%
Poorly correlated
+0.07%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with KYMR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
-2.45%
KYMR - VTYX
46%
Loosely correlated
+1.04%
IMNM - VTYX
44%
Loosely correlated
+2.21%
FDMT - VTYX
42%
Loosely correlated
+3.20%
SYRE - VTYX
41%
Loosely correlated
+7.60%
ABUS - VTYX
41%
Loosely correlated
+2.68%
More